* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
Download Alteration in the Cycle Length Dependence of Action Potential
Survey
Document related concepts
Epigenetics of neurodegenerative diseases wikipedia , lookup
Artificial gene synthesis wikipedia , lookup
Therapeutic gene modulation wikipedia , lookup
Gene therapy of the human retina wikipedia , lookup
Gene therapy wikipedia , lookup
Designer baby wikipedia , lookup
Transcript
Medical Research Society calculated. HT p.tlmts were divided into two groups accordingto their response to &blocker: good rerpondsrr (n=35) and noniespondwr (n-1)who w e d e R d by a BP fall >25/10 mmHg of 45/10 mmHg. rerpedivdy. Thdr genomic D N k were analysed for genotypes of exon 5 polymorphism b identifying the presence (+) or absence (-) of the M restridion rite of FCR-empli exon 5 DNA fragments. Rnu)t.: The genotype dislributlon of Fdrl--. Fdrl-+ and Wi++ was 4:19:12 in the good rospondera and 8:134 in the non-rerponden ( ~ =4.929. 2 0.1>pW0.05). SignMcanl diffamncorware observed in the frequency of the Fokland Fdrl+ alleles among chromcnomes in the good rasponden (2743) and nonresponden (2921: x2 a.423. p<0.05). Cornpariaom of changes in BP among lhe three genotypeswas arreued by one-way analysis of variance (meaniSEM): M-+ FdrlM++ F P 16 - n 12 32 Age (Y) 52.67i3.83 57.3li1.80 54.75f2.36 0.91 0.407 Weight (Kg) 83.43i6.20 81.oM3.57 77.933.45 0.30 0.743 SBPpre 165.5053.37 17O.CW2.68 178.44i6.33 1.98 0.147 150.83f5.36 146.78i3.82 147.56f4.62 0.18 0.839 30.88f5.38 2.80 0.069 14.67f4.09 23.28i3.05 0.17fo.03 2.18 0.122 ASBP/SBPpre 0.09M.02 0.14fo.02 ga.g~i4.x 1w.mii.a iio.8ii3.93 3.57 0.035 m . i g ~ m 0.14 0.871 90 wf3.42 88.9iii.88 20.63i3.45 4 01 0.023 ADB$lt 8.33f2.40 15.75i1.95 0.18fo.03 3.67 0.032 ADBP/DBP,,, 0.08iC 03 0.15iC.M gpst ;;p Conclusions: The results show that subjects homozygous for me Fokl++ have a better response to p-blocker therapy. indicating a correlation between G,a genotype and P-blockademediated lowering of BP in this HT group. This finding. if confirmed in a larger study. could have clinical implicationsfor treatment of EH. MU A~TERATION IN THE CYCLE LENGTH DEPENDENCE OF ACTION POTENTIAL DURATION BY ISCHAEMIA IN THE HUMAN HEART - RELEVANCB TO ARRHYTHMOGENBSIS BY A PREMATURE BEAT 19~ clinical features; hypogonadotrphic hypogonadism (IH€i)and anemia (absence of olfaction). This disorder can be inherited as an autosomal dominant, autosomal recessive, or X-linked trait or can be sporadiiin origin. KS affects 1 in l0,OOO males and 1 in 50,OOO f d c s , suggesting that the X-linked form is more common. The KAL gene is thought to be responsible b r the X-linked brm of KS has been isolated on Xp22.3 and its product is thought to play a role in the growth of the olfactory nerve into the forebrain and the concurrent migration of GnRH neurons along it into the mediobasal hypothalamus. We report a study performed on a patient group consisting of patients , KS ~ 8X-linked , KS FI 1 With autosod dominant KS ~ 3sporadic and MH n=4. The presence or absence of each of the 14 CXOIIS of the KAL gene was investigated using the polymaase chain m a i o n (PCR). DNA was extracted h m whole blood, and lug was used together with lOmM dNTP's and ImM MgCI, in a 30 cycle reaction (denature WO-1 min, annealing 55"-lmin, extension 72O-lmin). RESULTS: All 14 exons were present in patients with autosomid dominant KS; this is as expected since KAL is not thought to be involved in this form of KS. Two patients had an exon missing in the sporadic group, and in the X-linked group there were four patient With one exon missing each and three with complete gene deletions. In the LHH group only one patient had one exon missing. This data suggests that complete deletions or complete absence of an exon is rare and that the disease is probably due to point mutations in the coding, promoter, or downstream regions of the KAL gene. P TAGGAFLT,PMI SIPITON,MR BOYEm,MJ LAB and RH SWANTON Departments of Academic and Clinical Cardiology, UCL Hospitals, Departments of Physiology, Charing Cross Hospital, London anduniversity of Leeds We present evidence in the human heart that ischaemia alters the normal relation between action potential duration (APD)and cycle length in a manner which may greatly facilitate arrhythmogenesis by apremature beat. Monophasic action potentials were recorded in 14 patients (22 sites) from the right ventricular septum during angioplasty of a mid left anterior descending coronary arterylesion. Atest pulse sequence with shorter and longer coupling intervals was incorporated. Under control conditions test beats with the shortest coupling interval had the shortest APDs and test beats with the longer coupling interval had a longer APD. This resulted in a rising curvilinear relationship between increasing APD and increasing diastolic interval. During ischaemia the APD dependence on cycle length was minimised thereby flattening the curve: eg, at shortest intervals APD shortening (control 16.7*1.7ms; ischaemia 0.14i1.2ms; P<O.OOOl) and at long intervals APD lengthening (control 5.5k2.0ms; ischaemia 0.5*1.0ms; Pc0.05). We conclude that ischaemia rapidly diminishes the cycle length dependence of APD in the human heart. This may result in a voltage gradient sufficient to reexcite across and ischaemic border zone at short coupling intervals. Mb5 MUTATION ANALYSIS IN PATIENT WITH KALLMANN'S SYNDROME USING THE POLYMERASECEAIN REACTION V M Duke, P A d e Zoysa, R Quinton 8 n d P M G Boulous.* Division of Endocrinology, R F H W & UCLMSJoint Departments of Medicine, Rowland Hill Slreet, London NW3 2@. KallmaM'sSyndrome(KS) is described by the association of two main M66 MEASUREMENT OF LIPID PROFlLES POST-STROKE RJ BUITERWORTH. WJ MARSHALLand PMW BATH Departments of Medicine and Clinical Biochemistry. King's College School of Medicine and Dentistry. London. SE59PJ Introduction: Atherosclerosis is a major risk factor for stroke whilst serum lipid profiles may predict atherosclerotic risk. Lipids change following myocardial infarction but less is known about stroke. Mctboda: Fasting lipid p f i l e s were obtained from 57 acute strdrc patients (17cerebral infardon.4 primary intracerebra! hacmorrhage) at <48 hours, one week and three months post-ictus. Stroke was diagnosed on clinical and radiological grounds. Patients admittedon hypcrlipidacmic treatment were excluded. Results: Significant falls in total cholesterol calculated LDL cholesterol (LDL) and HDLcholesterol (HDL)were observed between admission and one week: in contrast. no change in triglyceridcs o c c u m d (table). There was no difference in total cholesterol between admission and at 3 months: mean (SD)5.81 (1.51) vs. 5.98 (1.36). difference -0.17 (95%CI -0.43 to 0.09. 2p=O. 19. n=32). Conclmsions: Total. HDL-and LDLchdesterd m u ~ u ~ m c oall ts fall significantly in the first week following stroke as occurs in myocardial infarction. The mechanism is *far unexplained. We suggest patients should be screened on admission or three months after stroke to avoid inaccurate lipid measurements. Koowlcdge of lipids after stroke may aid prevention of recurrent vascular dipcase includingstrokeand myocardial infadon. (To, Table. Serum lipids at admission and I week post- stroke, comparisons by paired t t a t .